A seguir

Reprodução automática

Dr. Yasmin Thanavala on targeted therapy for liver cancer

2 Visualizações • 06/28/23
Compartilhar
Embutir
administrator
administrator
Assinantes
0

Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2

Mostre mais
0 Comentários sort Ordenar por
Comentários do Facebook

A seguir

Reprodução automática